ATE245980T1 - Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern - Google Patents

Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern

Info

Publication number
ATE245980T1
ATE245980T1 AT96905942T AT96905942T ATE245980T1 AT E245980 T1 ATE245980 T1 AT E245980T1 AT 96905942 T AT96905942 T AT 96905942T AT 96905942 T AT96905942 T AT 96905942T AT E245980 T1 ATE245980 T1 AT E245980T1
Authority
AT
Austria
Prior art keywords
treatment
pyruvate dehydrogenase
limb ischemia
dehydrogenase activator
activator
Prior art date
Application number
AT96905942T
Other languages
English (en)
Inventor
Dumitru Constantin-Teodosiu
James Archibald Timmons
Paul Leonard Greenhaff
Simon Martin Poucher
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE245980T1 publication Critical patent/ATE245980T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT96905942T 1995-03-14 1996-03-11 Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern ATE245980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9505082.9A GB9505082D0 (en) 1995-03-14 1995-03-14 Medicament
PCT/GB1996/000555 WO1996028151A2 (en) 1995-03-14 1996-03-11 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs

Publications (1)

Publication Number Publication Date
ATE245980T1 true ATE245980T1 (de) 2003-08-15

Family

ID=10771147

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96905942T ATE245980T1 (de) 1995-03-14 1996-03-11 Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern

Country Status (7)

Country Link
EP (1) EP0814801B1 (de)
JP (1) JPH11501653A (de)
AT (1) ATE245980T1 (de)
AU (1) AU4950296A (de)
DE (1) DE69629282T2 (de)
GB (1) GB9505082D0 (de)
WO (1) WO1996028151A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804648D0 (en) * 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
GB9811427D0 (en) 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
GB9811932D0 (en) * 1998-06-04 1998-07-29 Zeneca Ltd Chemical compunds
AU6715200A (en) 1999-09-04 2001-04-10 Astrazeneca Ab Amides as inhibitors for pyruvate dehydrogenase
DK1214296T3 (da) 1999-09-04 2004-07-05 Astrazeneca Ab Substituerede N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluorpropanamidderivater, der forhöjer pyruvatdehydrogenaseaktivitet
DE60031699T2 (de) 1999-09-04 2007-08-30 Astrazeneca Ab Hydroxyacetamidobenzolsulfonamidderivate

Also Published As

Publication number Publication date
EP0814801B1 (de) 2003-07-30
AU4950296A (en) 1996-10-02
DE69629282D1 (de) 2003-09-04
WO1996028151A3 (en) 1997-01-23
WO1996028151A2 (en) 1996-09-19
JPH11501653A (ja) 1999-02-09
DE69629282T2 (de) 2004-04-22
GB9505082D0 (en) 1995-05-03
EP0814801A2 (de) 1998-01-07

Similar Documents

Publication Publication Date Title
DE60130023D1 (de) Behandlung der nebenwirkungen von statinen
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
TR200100610T2 (tr) Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
DE60112055D1 (de) Inhibitoren von gamma-secretase
DE59308619D1 (de) Germicide wirkstoffkombinationen
NO20003233L (no) 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler
FI942423A0 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
BG101138A (en) The use of glyceryltriacetate for the treatment of onychomycosis
AU5493296A (en) 6-carboxamido dihydropyran derivatives
ATE174786T1 (de) Orale präparate zur behandlung von plaque und gingivitis, die einen nicht-kationischen antibakteriellen wirkstoff und ein bikarbonatsalz enthalten
ATE245980T1 (de) Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern
ATE151288T1 (de) N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
ES2163528T3 (es) Una solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.
DE69708109D1 (de) Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben
NO179009C (no) Analogifremgangsmåte for fremstilling av salter av L-alfa-glyserofosforyl-D-myo-inositol
HUP0002727A2 (hu) Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával
ATE231838T1 (de) N,n'-diacylthiocystine
DE68919301D1 (de) Verwendung eines Prolylendopeptidase-Inhibitors zur Behandlung von AIDS.
NO955093D0 (no) 14-substituerte marcfortiner og derivater som er anvendbare som antiparasittiske midler
TR199801887A2 (xx) Bir Na+/H+ - de�i�tiricisi inhibit�r�.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties